Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The fecal neutrophil-derived biomarker calprotectin has several features of an ideal noninvasive test for detecting intestinal inflammation: it is simple, reliable, and low in cost. Its utility in differentiating inflammatory bowel diseases (IBDs) from functional conditions such as irritable bowel syndrome is well documented. Fecal calprotectin (FC) correlates closely with endoscopic activity of IBD. Emerging evidence suggest its usefulness in serial monitoring of disease activity and of therapy success in IBD. A low FC concentration predicts persistence of clinical remission especially in non-symptomatic ulcerative colitis and Crohn's colitis. Here, an overview is given to the current role of FC in diagnosis and clinical assessment of IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tibble, J. A., Sigthorsson, G., Bridger, S., Fagerhol, M. K., & Bjarnason, I. (2000) · Gastroenterology · doi:10.1053/gast.2000.8523 · Cited by 759 · cited 2×
“…non-relapsed patients mg/g Median FC in relapsed patients mg/g Sensitivity of FC in predicting relapse % Specificity of FC in predicting relapse % Tibble et al. (2000) [58] CD UC 43 37 250† 210† 145† 610† 615† 90 (CD and UC) 83 (CD and UC) Costa et al. (2005) [59] CD UC 38 41 150 150 221 67 220…”
Background
Cited by
Lamb, C. A., Kennedy, N. A., Raine, T., Hendy, P. A., Smith, P. J., Limdi, J. K., Hayee, B., Lomer, M. C. E., Parkes, G. C., Selinger, C., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318484 · Cited by 2,346
Microbiome risk profiles as biomarkers for inflammatory and metabolic disorders
Metwaly, A., Reitmeier, S., & Haller, D. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00581-2 · Cited by 264
Zollner, A., Schmiderer, A., Reider, S. J., Oberhuber, G., Pfister, A., Texler, B., Watschinger, C., Koch, R., Effenberger, M., Raine, T., et al. (2021) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjaa124 · Cited by 95
Pediatric Inflammatory Bowel Disease
Conrad, M. A., & Rosh, J. R. (2017) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2017.01.005 · Cited by 86
Cheng, Y., Hall, T. R., Xu, X., Yung, I., Souza, D., Zheng, J., Schiele, F., Hoffmann, M., Mbow, M. L., Garnett, J. P., et al. (2022) · eBioMedicine · doi:10.1016/j.ebiom.2021.103758 · Cited by 66
Metadata
- Authors
- Sipponen, T., & Kolho, K.-L.
- Venue
- Scandinavian Journal of Gastroenterology
- Publisher
- Informa UK Limited
- Published
- 2014-12-19
- Volume
- 50
- Issue
- 1
- Pages
- 74-80
- ISSN
- 0036-5521 (ISSN-L)
- 1502-7708
- OpenAlex
- W2052794841
- Cited by
- 125
- References
- 1
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease. https://app.cochat.ai/papers/10.3109/00365521.2014.987809
- The paper
- Sipponen, T., & Kolho, K.-L. (2015). Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease. Scandinavian Journal of Gastroenterology. https://doi.org/10.3109/00365521.2014.987809
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.